Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
American Journal of Clinical Pathology|November 13, 2014
HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancerHee Jin Lee, An Na Seo, Eun Joo Kim, et al.
Korean Journal of Radiology|March 31, 2026
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine TherapyMinseung Suh, Jeongryul Ryu, Hojin Song, et al.
Cancer Research and Treatment|December 27, 2024
Prognostic Performance of the Next-Generation Sequencing-Based Multigene Assay in Early Breast Cancer Patients Treated According to the 21-Gene Assay ResultsEunhye Kang, Jong-Ho Cheun, Jeeyeon Lee, et al.
BMC Cancer|December 11, 2014
Preoperative serum HER2 extracellular domain levels in primary invasive breast cancerSae Byul Lee, Jong Won Lee, Jong Han Yu, et al.
Blood|March 21, 2007
Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growthHaiming Chen, Melinda S Gordon, Richard A Campbell, et al.
Cancer Research and Treatment|December 23, 2021
The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast CancerIn Hye Song, Young-Ae Kim, Sun-Hee Heo, et al.
Clinical Breast Cancer|October 19, 2025
Clinical Benefit of Adjuvant Capecitabine According To Residual Cancer Burden in Patients With Triple-Negative Breast Cancer With Residual Disease Following Neoadjuvant ChemotherapyShinyoung Lee, Hyehyun Jeong, Eunju Shin, et al.
British Journal of Cancer|April 27, 2016
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancerAn Na Seo, Hee Jin Lee, Eun Joo Kim, et al.
International Journal of Cancer|September 17, 2023
21-gene expression assay and clinical outcomes of premenopausal patients with hormone receptor-positive breast cancerJaewon Hyung, Sae Byul Lee, Jisun Kim, et al.
Journal of Breast Cancer|January 7, 2021
The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In SituChoong Man Lee, Il Yong Chung, Yangsoon Park, et al.
Pageof 24